Rocket Pharmaceuticals (RCKT) EPS (Basic) (2014 - 2026)
Rocket Pharmaceuticals (RCKT) reported EPS (Basic) of -$0.42 for Q1 2026, up 23.81% on a YoY basis from -$0.34 in Q1 2025, and down 10.88% sequentially from -$0.38 in Q4 2025.
Rocket Pharmaceuticals (RCKT) EPS (Basic) (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 13 years of EPS (Basic) data on file, last reported at -$0.42 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 23.81% year-over-year to -$0.42; the trailing twelve-month figure through Mar 2026 stood at -$1.87 (up 20.33% YoY), and the FY2025 full-year result was -$2.01, up 26.43% from the prior year.
- EPS (Basic) declined to -$0.42 in Q1 2026, from -$0.38 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.38 in Q4 2025 to a low of -$0.98 in Q4 2022.
- A 5-year average of -$0.68 and a median of -$0.71 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 51.76% in 2022 and surged 39.84% in 2025, its largest moves.
- Tracing RCKT's EPS (Basic) over 5 years: stood at -$0.98 in 2022, then rose by 27.47% to -$0.71 in 2023, then advanced by 10.4% to -$0.64 in 2024, then surged by 39.84% to -$0.38 in 2025, then retreated by 10.88% to -$0.42 in 2026.
- Business Quant data shows RCKT's EPS (Basic) at -$0.42 in Q1 2026, -$0.38 in Q4 2025, and -$0.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Rocket Pharmaceuticals | 359.39 Mn | 359.39 Mn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.45 |
| Jun 30, 2025 | -0.62 |
| Mar 31, 2025 | -0.56 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | -0.71 |
| Jun 30, 2024 | -0.74 |
| Mar 31, 2024 | -0.66 |
| Dec 31, 2023 | -0.71 |
| Sep 30, 2023 | -0.75 |
| Jun 30, 2023 | -0.82 |
| Mar 31, 2023 | -0.73 |
| Dec 31, 2022 | -0.98 |
| Sep 30, 2022 | -0.87 |
| Jun 30, 2022 | -0.83 |
| Mar 31, 2022 | -0.67 |
| Dec 31, 2021 | -0.70 |
| Sep 30, 2021 | -0.79 |
| Jun 30, 2021 | -0.55 |